Top Markets
Coin of the day
Monterey Bio Acquisition Corporation Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRY
Rangering i aksjer #19503
Monterey Bio Acquisition Corporation currently lacks substantial operational... Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
Aksjekurs
$11.14
Sist synkronisert: 2023-11-28
Markedsverdi
$160.14M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Monterey Bio Acquisition Corporation (MTRY)
P/S-forhold for Monterey Bio Acquisition Corporation (MTRY)
P/S-forhold per 2026 TTM: 0
Ifølge Monterey Bio Acquisition Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Monterey Bio Acquisition Corporation fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter